Minimal (clinically) important differences for the Fatigue Assessment Scale in sarcoidosis

Respiratory Medicine

Volumn 105, Issue 9, 2011, Pages 1388-1395

  De Kleijn, Willemien P E ^a,b   De Vries, Jolanda ^a,b,c   Wijnen, Petal A H M ^b   Drent, Marjolein ^b  

^a TILBURG UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CPRLab   (Netherlands)

Author keywords

Fatigue; Fatigue Assessment Scale; Minimal clinically important difference; Sarcoidosis

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; FATIGUE; FATIGUE ASSESSMENT SCALE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG DIFFUSION CAPACITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; DISABILITY EVALUATION; FATIGUE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NETHERLANDS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SARCOIDOSIS, PULMONARY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 79960440679     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2011.05.004     Document Type: Article

References (43)

1. W.P. de Kleijn, J. De Vries, and E.E. Lower Fatigue in sarcoidosis: a systematic review Curr Opin Pulm Med 15 2009 499 506
2. H.J. Michielsen, M. Drent, T. Peros-Golubicic, and J. De Vries Fatigue is associated with quality of life in sarcoidosis patients Chest 130 2006 989 994 (Pubitemid 44583726)
3. H.J. Michielsen, T. Peros-Golubicic, M. Drent, and J. De Vries Relationship between symptoms and quality of life in a sarcoidosis population Respiration 74 2007 401 405 (Pubitemid 47093152)
4. R.M. Wirnsberger, J. De Vries, and M.H. Breteler Evaluation of quality of life in sarcoidosis patients Respir Med 92 1998 750 756 (Pubitemid 28279449)
5. M.D. Elfferich, P.J. Nelemans, and R.W. Ponds Everyday cognitive failure in sarcoidosis: the prevalence and the effect of anti-TNF-alpha treatment Respiration 80 2010 212 219
6. Marcellis RG, Lenssen AF, Elfferich MD, et al. Exercise capacity, muscle strength and fatigue in sarcoidosis. Eur Respir J, in press.
7. J. De Vries, and M. Drent Relationship between perceived stress and sarcoidosis in a Dutch patient population Sarcoidosis Vasc Diffuse Lung Dis 21 2004 57 63 (Pubitemid 38533815)
8. J. De Vries, H. Michielsen, G.L. Van Heck, and M. Drent Measuring fatigue in sarcoidosis: the Fatigue Assessment Scale (FAS) Br J Health Psychol 9 2004 279 291 (Pubitemid 39277403)
9. H.J. Michielsen, J. De Vries, G.L. Van Heck, F.J.R. Van de Vijver, and K. Sijtsma Examination of the dimensionality of fatigue: the construction of the Fatigue Assessment Scale (FAS) Eur J Psychol Assess 20 2004 37 48
10. J. De Vries, S. Rothkrantz-Kos, M.P. van Dieijen-Visser, and M. Drent The relationship between fatigue and clinical parameters in pulmonary sarcoidosis Sarcoidosis Vasc Diffuse Lung Dis 21 2004 127 136 (Pubitemid 38954753)
11. R.P. Baughman, B.K. Sparkman, and E.E. Lower Six-minute walk test and health status assessment in sarcoidosis Chest 132 2007 207 213 (Pubitemid 47068223)
12. E.E. Lower, S. Harman, and R.P. Baughman Double-blind, randomized trial of dexmethylphenidate hydrochloride for the treatment of sarcoidosis-associated fatigue Chest 133 2008 1189 1195 (Pubitemid 351685525)
13. R. Jaeschke, J. Singer, and G.H. Guyatt Measurement of health status. Ascertaining the minimal clinically important difference Control Clin Trials 10 1989 407 415 (Pubitemid 20025670)
14. A. Purcell, J. Fleming, S. Bennett, B. Burmeister, and T. Haines Determining the minimal clinically important difference criteria for the Multidimensional Fatigue Inventory in a radiotherapy population Support Care Cancer 18 2009 307 315
15. J. Pouchot, R.B. Kherani, and R. Brant Determination of the minimal clinically important difference for seven fatigue measures in rheumatoid arthritis J Clin Epidemiol 61 2008 705 713
16. E.C. Goligher, J. Pouchot, and R. Brant Minimal clinically important difference for 7 measures of fatigue in patients with systemic lupus erythematosus J Rheumatol 35 2008 635 642 (Pubitemid 351500059)
17. D. Cella, D.T. Eton, J.S. Lai, A.H. Peterman, and D.E. Merkel Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales J Pain Symptom Manage 24 2002 547 561 (Pubitemid 36120443)
18. D.A. Revicki, D. Cella, and R.D. Hays Responsiveness and minimal important differences for patient reported outcomes Health Qual Life Outcomes 4 2006 70
19. D. Revicki, R.D. Hays, D. Cella, and J. Sloan Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes J Clin Epidemiol 61 2008 102 109
20. R.D. Crosby, R.L. Kolotkin, and G.R. Williams Defining clinically meaningful change in health-related quality of life J Clin Epidemiol 56 2003 395 407 (Pubitemid 36694091)
21. Statement on sarcoidosis. Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999 Am J Respir Crit Care Med 160 1999 736 755
22. World Health Organization WHOQOL user manual 1998 Geneva
23. The WHOQOL Group Development of the World Health Organization WHOQOL-BREF quality of life assessment Psychol Med 28 1998 551 558
24. S.M. Skevington, M. Lotfy, and K.A. O'Connell The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL Group Qual Life Res 13 2004 299 310 (Pubitemid 38392258)
25. G.R. Norman, J.A. Sloan, and K.W. Wyrwich Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation Med Care 41 2003 582 592
26. J.W. Cohen Statistical power analysis for the behavioral sciences 1988
27. K.W. Wyrwich, W.M. Tierney, and F.D. Wolinsky Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life J Clin Epidemiol 52 1999 861 873 (Pubitemid 29385600)
28. K.W. Wyrwich, N.A. Nienaber, W.M. Tierney, and F.D. Wolinsky Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life Med Care 37 1999 469 478
29. D.E. Beaton, C. Bombardier, J.N. Katz, and J.G. Wright A taxonomy for responsiveness J Clin Epidemiol 54 2001 1204 1217 (Pubitemid 34002973)
30. N.S. Jacobson, and P. Truax Clinical significance: a statistical approach to defining meaningful change in psychotherapy research J Consult Clin Psychol 59 1991 12 19
31. M.H. Zweig, and G. Campbell Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine Clin Chem 39 1993 561 577 (Pubitemid 23118304)
32. H.C. de Vet, R.W. Ostelo, and C.B. Terwee Minimally important change determined by a visual method integrating an anchor-based and a distribution-based approach Qual Life Res 16 2007 131 142 (Pubitemid 46046743)
33. A.G. Copay, B.R. Subach, S.D. Glassman, D.W. Polly Jr., and T.C. Schuler Understanding the minimum clinically important difference: a review of concepts and methods Spine J 7 2007 541 546 (Pubitemid 47471437)
34. D. Hosmer, and S. Lemeshow Applied logistic regression Applied logistic regression 2000 Wiley Inc New York 156 164
35. J. Rejas, A. Pardo, and M.A. Ruiz Standard error of measurement as a valid alternative to minimally important difference for evaluating the magnitude of changes in patient-reported outcomes measures J Clin Epidemiol 61 2008 350 356 (Pubitemid 351308068)
36. A.E. Holland, C.J. Hill, M. Conron, P. Munro, and C.F. McDonald Small changes in six-minute walk distance are important in diffuse parenchymal lung disease Respir Med 103 2009 1430 1435
37. J.J. Swigris, K.K. Brown, and J. Behr The SF-36 and SGRQ: validity and first look at minimum important differences in IPF Respir Med 104 2009 296 304
38. J.W. Kocks, M.G. Tuinenga, and S.M. Uil Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire Respir Res 7 2006 62
39. A.L. Quittner, A.C. Modi, and C. Wainwright Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection Chest 135 2009 1610 1618
40. R.M. du Bois, D. Weycker, and C. Albera 6-Minute walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference Am J Respir Crit Care Med 183 2011 1231 1237
41. D. Turner, H.J. Schunemann, and L.E. Griffith The minimal detectable change cannot reliably replace the minimal important difference J Clin Epidemiol 63 2010 28 36
42. J.J. Swigris, F.S. Wamboldt, and J. Behr The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference Thorax 65 2010 173 177
43. M.C. Iannuzzi, B.A. Rybicki, and A.S. Teirstein Sarcoidosis N Engl J Med 357 2007 2153 2165